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Directional conformer exchange in dihydrofolate reductase revealed by 




Conformational heterogeneity is emerging as a defining characteristic of enzyme function. 
However, understanding the role of protein conformations requires their thermodynamic and 
kinetic characterization at the single-molecule level, which remains extremely challenging. 
Here we report the ligand-induced conformational changes of dihydrofolate reductase 
(DHFR) by measuring the modulation of the nanopore currents. The long observation time of 
the electrical recordings enabled the detection of rare conformational transitions hidden in 
ensemble measurements. We show that DHFR exists in at least four ground-state 
configurations or conformers with different affinities for its ligands. Unliganded DHFR 
adopted low-affinity conformers, whereas the binding of substrates promoted the switch to the 
high-affinity conformer. Conversion between the conformers was accelerated by molecules 
that stabilized the transition state of DHFR, which suggests that the reaction lowers the energy 
barrier for conformer exchange and thus facilitates product release. This mechanism might be 
a general feature in enzymatic reactions affected by product inhibition or when the release of 
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Since the structure of lysozyme was revealed 50 years ago1, it has long been accepted that 
natural enzymes possess unique evolutionarily conserved three-dimensional structures, which 
aim is to stabilize the transition state of the catalysed reaction2. Yet, over the years, a wealth of 
evidences came to question this simplistic view of enzyme reactions. It is now accepted that the 
free-energy landscape of folded proteins exists as an ensemble of conformations in fast thermal 
equilibrium around their energetically stable ground state. This collection of conformation 
plays a crucial role in events such as the binding of substrates, preorganization, transition-state 
stabilization, product release, or allosteric regulation3. More recently, it has been further 
observed that proteins might adopt more than one ground-state folded structure. In such 
‘metamorphic’ proteins, the backbone interactions spontaneously and reversibly rearrange over 
several seconds4,5. As enzymes work best at the edge of their thermal stability where exchanges 
in conformations are faster6–11, it is likely that both fast and slow structural transitions are 
important for the catalytic function of many enzymes. However, the functional understanding 
of the structural heterogeneity in enzymes requires measuring the thermodynamics and kinetics 
of the different enzyme populations at the single-molecule level, which remains a daunting task, 
especially for small globular enzymes.  
 
Dihydrofolate reductase (DHFR) catalyses the reduction of dihydrofolate (DHF) to 
tetrahydrofolate (THF) using NADPH as cofactor (Fig. 1A). Tetrahydrofolate acts itself as a 
cofactor for the de novo synthesis of purines, thymidylic acid, and certain amino acids. 
Extensive structural characterizations revealed that DHFR adopt several different 
conformations during the catalytic cycle12–18. Ensemble kinetic experiments revealed that in a 
variety of species, such as Lactobacillus casei19, Gallus20, Mus musculus21 and Escherichia 
coli22–24, DHFR adopts two distinct forms showing different kinetic constants. In E. coli DHFR, 
these two DHFR forms can be separated by affinity chromatography using a methotrexate 
(MTX) column, which indicates they have a difference affinity for this inhibitor25. The two 
forms slowly interconverted at a rate of 0.035 s-1 26, which reveals that they represent two 
different ground-state conformers of apo-DHFR. NMR studies from different sources have later 
confirmed that the ground-state conformation heterogeneity is a common feature in DHFR27–
29. Single-molecule fluorescence studies also confirmed that DHFR binds to methotrexate with 
two different affinities15. However, the characterization of the rapidly exchanging ligand-
induced configurations of DHFR could not be observed. Hence, it is unknown how many 
conformers of DHFR exist, whether only one24 or two30 can bind to NADPH, whether the 
affinity for the substrates is the same31 or different15, and what their role is in the kinetic cycle 
of the enzyme.  
 
Over the past decade and a half, ionic currents through individual nanopores emerged as 
powerful tools to study chemical reactions at the single-molecule level32–38. Initial efforts to 
study enzymes used small nanopores (diameters less than 2 nm) to monitor the activity of 
enzymes binding to the nanopore39, to detect the products of enzymatic reactions40–43, or to 
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monitor enzymes operating directly above the nanopore39,44–50. The observation of an enzymatic 
reaction inside a nanopore, which would allow monitoring the kinetics of single enzymes in 
real-time, required using larger nanopore and developing new immobilization techniques. 
Recently, we reported that by using a Cytolysin A (ClyA-AS), a nanopore from Salmonella 
Typhi which has been modified for protein analysis nanopore51 (inner diameter ~ 5 nm, (Fig. 
1B)), globular proteins may enter the lumen of the nanopore impelled by the electroosmotic 
flow, and remain confined between the larger and narrow openings of the pore from a few 
seconds up to hours52–54. Changes in conformations are then observed by modulation of the 
nanopore current52,55–58. For all proteins analysed so far, the confinement inside the nanopore 
had no effect on the thermodynamic or kinetics of ligand binding53,56,59. Thus, nanopore currents 
can be used to monitor native proteins for extensive time and with high sampling frequency, 
which is difficult with other single-molecule techniques.  
In this work we investigated the ligand-induced conformational changes of DHFR. We found 
that the enzyme exists in at least four ground-state configurations each having a distinctive 
affinity for different ligands. Remarkably, exchange between the conformers was induced by 
the binding of substrates and was accelerated on visiting the transition-state conformation. Our 
results suggest a model in which the folded landscape of DHFR is imprinted with multiple 
ground-state conformations that show different affinities for their ligands and exchange along 
the reaction coordinates. This framework might allow tuning the affinity of the enzyme for its 
ligands during the different catalytic steps and might be instrumental to accelerate product 
release, which is the rate-limiting step in the DHFR reaction. 
3.2  Results 
3.2.1  Binding of ligands to nanopore-trapped DHFR 
 
In nanopore recordings, a protein enters the nanopore impelled by the electroosmotic 
flow52,59,60. This process is visualized by the reduction of the open pore current (IO) to the 
blocked pore current (IB). The residual current percentage of the blockade is then defined as 
Ires% = IB/IO × 100. Wild-type DHFR escaped the nanopore too quickly to be studied
52. Hence, 
to trap DHFR inside the ClyA nanopores for tens of seconds, a dipole was engineered on the 
surface of a cysteine-free DHFR by replacing two non-conserved amino acids with glutamic 
acid residues (T68E and R71E) and introducing a lysine-rich N-terminal extension polypeptide 
tag (named here as DHFRtag, (Fig. 1B))
59. The modifications to the enzyme surface charge did 
not alter the properties of the protein, with the exception of a slightly reduced kcat (about two-
fold, additional information and Supplementary Table 1). At a negatively applied potential 
(e.g. -80 mV), DHFRtag added to the cis side of ClyA-AS entered the nanopore, as observed by 







Figure 1. DHFR inside the ClyA-AS nanopore. (A) DHFR catalysed reaction. (B) Depiction of a 
single cysteine-free (C85A and C152S substitutions) DHFR molecule extended with a C-terminal 
polypeptide tag and the two additional mutations (T68E, R71E) inside a ClyA-AS nanopore (brown). 
(C) Typical current trace after the addition of ~50 nM DHFRtag to a single ClyA-AS nanopore in cis at 
-80 mV applied potential (trans). The red dashed line shows the open-pore current (IO, -273.3 ± 3.0 pA) 
and the green dashed lines the blocked pore current (IB). The current trace was collected in 250 mM 
KCl, 15 mM Tris-HCl pH 7.8 at 23 ºC. Data were sampled at 10 kHz and a Bessel-low pass filter with 
a 2 kHz cut-off was applied. The trace was then filtered digitally with a Gaussian low-pass filter with a 
500 Hz cut-off.  
 
When NADPH was also added to the cis chamber, three kinds of DHFRtag blockades were 
observed (Fig. 2A). The majority (65.5 ± 0.8%, N = 3 independent nanopores experiments, n = 
469 protein blockades, which each protein blockades including tens to hundreds ligand-binding 
events) showed reversible current enhancements from E1 apo-enzyme (E1) (Ires% = 75.7 ± 0.3 
with Ires% indicating the amount of current left during the blockade, expressed as a percentage 
of the open-pore current, Supplementary Table 2) to E1:NADPH (E1:NH) (ΔIres% = 1.36 ± 
0.04%). 24.1 ± 3.4% of protein blockades showed reversible current enhancements from a 
second blocked current level E2 (Ires% = 75.4 ± 0.3) to E2:NH (ΔIres% = 1.25 ± 0.03%). The 
remaining protein blockades (10.4 ± 2.9%) showed no additional current events (Fig. 2B). 
Rarely (3.9 ± 1.8%, N = 8, n = 1598 protein blockades), inter-conversion between the different 
kinds of current blockades were observed (Supplementary Fig. 1). The percentage distribution 
of DHFRtag blockade types did not depend on the inner surface composition of the nanopore 
(Supplementary Fig. 2), suggesting that they are unlikely to reflect an interaction between the 
protein and the nanopore walls. Substrate binding was tested using folate, a slow-reacting 
substrate of DHFR61. Folate also induced three different kinds of current enhancements to 
DHFRtag blockades. 39.7 ± 8.2% (N = 4, n = 624 protein blockades) of blockades showed 
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reversible enhancements from E1 apo-enzyme to E1:folate (E1:f) (ΔIres = 0.79 ± 0.02%), 13.0 
± 2.3% of blockades showed enhancement from an additional blocked level E3 (Ires% = 76.0 ± 
0.1%) to E3:f (ΔIres% = 0.61 ± 0.05%), and 47.3 ± 6.7% of blockades showed no additional 
current levels (Fig. 2C).  
 
 
Figure 2. Binding of NADPH and folate to DHFRtag reveals the different DHFR conformers. (A) 
Current trace showing the capture of the different DHFRtag conformers inside ClyA-AS at -80 mV 
applied potential. After adding 26.6 µM NADPH to the cis compartment additional ligand-induced 
current enhancements are observed reflecting the binding of NADPH to DHFRtag. Three types of DHFR 
protein blockades are observed based on affinity and residual current and categorised by a blue box (low 
affinity NADPH binding), a pink box (high affinity NADPH) or a green box (no ligand-induced events). 
(B) Left, zoom-ins showing three typical NADPH-induced binding events to confined DHFRtag. 
NADPH binding is reflected by current enhancements from the unliganded enzyme (green dashed line) 
to the NADPH-bound enzyme (red dashed line) current levels. Right, all-point histograms of the shown 
current trace are depicted to define the different current blockades. (C) Left, zoom-ins of the three 
typical DHFRtag current blockade before and after addition of 20.0 µM folate to the cis compartment. 
Folate binding to confined DHFRtag is reflected by current enhancements from the unbound enzyme 
(green dashed line) to the folate-bound (purple dashed line) current level. Right, all-point histograms 





observed in 3.9 ± 1.8% of the events. The current trace was collected in 250 mM KCl, 15 mM Tris-HCl 
pH 7.8 at 23 ºC. Data were sampled at 10 kHz and a Bessel-low pass filter with a 2 kHz cut-off was 
applied. The traces were filtered digitally with a Gaussian low-pass filter with a 100 Hz cut-off. 
 
The frequency of the current enhancements increased with the concentration of the analyte 
added to the cis chamber, while their duration remained constant over the analyte concentration 
tested (Supplementary Fig. 3), indicating the current enhancements reflected the binding of 
ligands to three different conformers of DHFRtag named here E1, E2 and E3. DHFRtag molecules 
that showed no ligand induced blockades were labelled as E4. In order to distinguish whether 
E2 and E3 are separate conformers of DHFR, we measured DHFRtag blockades in the presence 
of both folate (33.6 µM, trans) and NADPH (26.6 µM, cis) (Fig. 3). E1 blockades showed four 
different current levels, corresponding to the apo-enzyme (E1), DHFR bound to E1, E1:NH, 
E1:f and E1 bound to both folate and NADPH (E1:NH:f). Such current blockades reflected 
the ligand-induced conformations visited by DHFR during the catalytic cycle as observed in 
many structural studies12–18. By contrast, E2 and E3 only showed E2:NH and E3:f, respectively, 
while E4 showed no additional blockades. Hence, E1, E2, E3 and E4 are likely to represent 
separate DHFR conformers, with only E1 being the catalytically competent form, as it is the 
only conformer that is capable of binding both the NADPH cofactor and the substrate.  
 
 
Figure 3: DHFR exist in four different DHFR conformers. (A) Top left, a typical current blockades 
induced by DHFRtag (~50 nM, cis) in the presence of NADPH (26.6 µM, cis) and folate (33.6 µM 
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trans) showing the E1 conformer (above, black), E2 (below, blue), E3 (below, purple) and E4 (below, 
green). Top right, all-point histograms of the shown current trace to define the different current 
blockades. (B) Histograms showing the mean occurrences of the different conformers. Error bars 
represent the standard deviation between independent experiments (N = 5). (C) Schematic representation 
of the pore and DHFRtag showing the reaction conditions. The current trace was collected in 250 mM 
KCl, 15 mM Tris-HCl pH 7.8 at 23 ºC. Data were sampled at 10 kHz and a Bessel-low pass filter with 
a 2 kHz cut-off was applied.  
 
The association rate constants (kon) of the ligands to E1, E2 and E3 were determined from the 
slope of the inverse of the inter-event times versus the concentration of the ligand tested, while 
the ligand dissociation rate constants (koff) were retrieved from the inverse of the ligand-induced 
dwell times (Supplementary Fig. 3, Supplementary Table 3). Once the rates was extrapolated 
to zero applied potential (Supplementary Fig. 3, Supporting Information), both the 
dissociation and association binding constants for folate and NADPH binding to E1 
corresponded reasonably well to the dissociation constants measured in bulk (Supplementary 
Table 3). Hence, as observed before for other proteins53,56,59, the confinement inside the 
nanopore did not have a strong effect on DHFRtag.  
3.2.2  DHFR Conformers 
 
It has been established that DHFR for a variety of species exist in at least two ground-state 
configurations or conformers22–25,30,62–67. Hence, a series of experiments were performed to 
prove that E1, E2, E3 and E4 represent a subset of DHFR conformers rather than experimental 
artefacts. It was reported that incubation of DHFR with NADPH increased the proportion of 
the conformer with high affinity for NADPH30,62. We found that when NADPH was added to 
the opposite side of the lipid bilayer with respect of DHFRtag (hence no preincubation), E1 was 
observed in only 20.7 ± 6.7% of blockades (N = 5, n = 865 protein blockades) (Fig. 4A, red). 
Conversely, when NADPH and DHFRtag were added to the same side of the nanopore (hence 
DHFRtag was incubated with NADPH) 65.5 ± 0.8% of blockades corresponded to the E1 (Fig. 
4A, grey), confirming the stabilizing effect of NADPH towards the active DHFR conformer. 
The same was observed when NADPH was first added to the trans side and then to the cis side 
(Fig. 4B, N = 3, n = 501 protein blockades). Interestingly, while co-incubation with folate in 
the cis chamber also enriched the proportion of E1 (Supplementary Fig. 2), co-incubation with 
oxidized nicotinamide adenine dinucleotide phosphate (NADP+) had no effect (Fig. 4C, N = 4, 
n = 313 protein blockades). The conformational equilibrium of the conformers was also 
examined with the D27N mutant (D27N-DHFRtag), which was reported to alter the distribution 
of conformers towards a catalytically not competent conformer30. Accordingly, we found that 
in the presence of NADPH in the cis chamber, E1 blockades decreased by about half (33.6 ± 
3.3% of the total), while E4 blockades increased five-fold (50.2 ± 3.4% of the total, Fig. 4D, N 
= 7, n = 740 protein blockades). Finally, it has been reported that the relative proportions of the 
more active conformer were pH dependent24,25. Again, we found that the percentage of E1 
blockades at pH 9.0 increased compared to pH 7.8 (Fig. 4D, N = 4, n = 490 protein blockades). 
These results also indicate that E1, E2 and E4 most likely represent three conformers of DHFR, 





Figure 4: DHFR conformer distribution depends on the reaction conditions. In each panel, on the 
left is the schematic representation of the reaction conditions, on the right is the histogram of the 
distribution of different DHFR conformers sampled. DHFRtag (~50 nM) was added to the cis solution. 
(A) Conformer distribution with NADPH (26.6 µM) added either to the trans side (red bars, red 
nanopore) (N = 5) or to the cis side (grey bars, grey nanopore) (N = 3). (B) Conformer distribution with 
NADPH (26.6 µM) added first to the trans side (red bars and red nanopore) and then using equimolar 
concentration to the cis side (grey and red bars, grey and red nanopore). Recording started 10 minutes 
after NADPH addition (N = 3). (C) Conformer distribution with folate (33.6 µM) added the trans side, 
and NADPH (26.6 µM, grey bars, grey nanopore) (N = 5) or NADP+ (1.5 µM, purple bars,) (N = 4) 
added to the cis side. (D) Conformer distribution tested using WT-DHFRtag at pH 7.8, (grey bars, grey 
nanopore) (N = 3), WT-DHFRtag at pH 9.0, (green bars) (N = 4), or D27N-DHFRtag at pH 7.8 (blue bars) 
(N = 7). NADPH (26.6 µM) was added to the cis side. Histograms showing the mean occurrences of the 
different conformers. Error bars represent the standard deviation between independent experiments.  
 
3.2.3  Binding of methotrexate to DHFR conformers  
 
Heterogeneity in the DHFR transition-state configuration was sampled using methotrexate 
(MTX), a molecule that is thought to induce DHFR to adopt the pseudo-Michaelis complex 
conformation12,68–70. As observed before in bulk24,64–66,71, two groups of apo-DHFRtag blockades 
were distinguished, one with higher (Kd
app(-80 mV) = 45 nM) and one with lower (Kd
app(-80 
mV) = 19 µM) affinity for methotrexate. Interestingly, all DHFRtag molecules could bind to 
methotrexate, confirming that all blockades reflected folded DHFRtag molecules. The binding 
of methotrexate to either E1 and E2 conformers was sampled by adding NADPH (80 µM) to 
the cis solution and methotrexate (1.4 µM) to the trans solution. Both E1:NH (ΔIres% = 1.84 ± 
0.10%) and E2:NH (ΔIres% = 1.99 ± 0.10%) blockades showed methotrexate binding (Fig. 5A), 
indicating that both conformers can form the pseudo-Michaelis complex. No dissociation of the 
ternary complex was observed during the time window of our experiments. NADP+ showed 
two different binding affinities for the methotrexate-bound structure (Supplementary Fig. 4). 
Intriguingly, interconversion between different NADP+ binding affinities was observed in 30.2 
± 3.2% of the blockades (N = 4, n = 193 protein blockades) (Fig. 5B).  
Glycine 121 to valine substitution is a well-studied DHFR mutant in which the catalytic 
function is reduced by ~100 fold, and the affinity for NADPH reduced by 40-fold16. At -80 mV, 
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the addition of NADPH (80 µM, cis) to G121V-DHFRtag did not elicit additional blockades 
(Supplementary Fig. 5), suggesting that the dissociation rate of NADPH from DHFRtag is too 
fast to be experimentally observed here. However, upon further addition of methotrexate (1.5 
µM, trans), step-wise enhancements of the ionic current (ΔIres = 1.8 ± 0.1 pA and 1.9 ± 0.2 pA) 
were observed reflecting the binding of NADPH to the DHFR:MTX binary complex. 
Interestingly, as observed for the ternary complex DHFRtag:MTX:NADPH, within the same 
protein blockade the interconversion between conformers was detected in 26.2 ± 5.9% of the 
blockades (N = 5, n = 142 protein blockades)(Fig. 5C). 
 
 
Figure 5: Exchange of conformers at the transition state. (A) Methotrexate (chemical structure 
depicted on right, 1.2 µM, trans) binding to E1 (left) and E2 (right) in the presence of NADPH (26.6 
µm, cis), showing that both conformer can reach the pseudo-Michaelis complex. (B) In the presence of 
NADP+ (32.2 µm, cis) and methotrexate (20 µM, trans) DHFRtag shows often conformer exchange (30.2 
± 3.2%). (C) Conformer exchange (26.2 ± 5.9%) was also observed using G121V-DHFRtag in the 
presence of NADPH (80 µM, cis) and methotrexate (1.5 µM, trans). The pink and blue boxes above the 
current blockades are a guide to the eye to distinguish the different DHFRtag conformers. On the right of 





in 250 mM KCl, 15 mM Tris-HCl pH 7.8 at 23 ºC. Data were sampled at 10 kHz and a Bessel-low pass 
filter with a 2 kHz cut-off was applied.  
 
3.3  Discussion 
 
In this work we investigated the conformational heterogeneity of DHFR using ClyA-AS 
nanopores. Ionic currents allowed sampling of the ligand-induced conformational changes of 
DHFR molecules immobilized inside the nanopore at the single-enzyme level, a task that was 
unattainable using single-molecule Förster resonance energy transfer (FRET) 
measurements.15,71 The association and dissociation rate constants for the binding of NADPH, 
folate and methotrexate to DHFR inside the nanopore corresponded well to the values measured 
by other ensemble techniques (Supplementary Table 2), indicating that the nanofluidic and 
electrophoretic forces, and the confinement inside the nanopore have no strong effect on the 
overall thermodynamic properties of the enzyme.53,56,59 Nanopore currents have the further 
advantage that the resolution of the measurement is not influenced by the photophysical 
instability of fluorescence dyes, and enzymatic processes can be sampled for long time51,55,72 at 
high sampling frequencies (Supplementary Fig. 6). In turn, this allowed sampling rare events 
shaping the conformational landscape of the enzyme, which could not be observed by ensemble 
experiments. 
 
The single-molecule analysis of individual blockades revealed that DHFR exists in at least four 
conformers, each having a different affinity for NADPH, NADP+, folate and methotrexate. 
These DHFR conformers should not be confused with the higher-energy ligand-bound 
conformations of DHFR observed by NMR and X-ray crystallography that are transiently 
visited during the enzyme catalytic cycle73–75. The latter are observed here as current 
enhancements (Fig. 2). By contrast, the conformers most likely represent four minima of the 
conformational landscape of the enzyme. As observed in metamorphic proteins4,5, they may 
include alternative folds of DHFR primary structure. We found that in complex with NADPH, 
the thermodynamically most stable conformer was the catalytically active conformer E1. 
However, when NADP+ was bound (or in the absence of ligands) the most stable form of DHFR 
was the low affinity conformer E2. This suggests that the folding free-energy difference 
between E1 and E2 facilitates the flow of the reaction from NADPH to NADP+. Interestingly, 
when methotrexate and nicotinamide cofactors (NADPH or NADP+) were bound, frequent 
interconversions between conformers of DHFR were observed (Fig. 5), indicating that the 
energy barrier between conformers was reduced. Since methotrexate is thought to induce the 
transition-state conformation of DHFR12,68–70, this suggests that the most favourable crossing 
between conformers is along the reaction coordinates. 
 
These results suggest an intriguing hypothesis to account for the DHFR conformers. It is 
generally accepted that the catalytic power of enzymes arises from their ability to bind transition 
states more tightly than ground states76. However, enzymes must also bind the substrates and 
release the products. The evolution of an active site with such characteristics might be 
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challenging, as epitomized by the failure of artificial enzymes selected for their ability of 
binding to transition-state analogues to capture the full catalytic power of natural enzymes77. 
One possible solution would be for enzymes to fold into multiple ground-state conformers, each 
having a different affinity for the different steps of the catalytic cycle. If the exchange between 
conformers is only allowed along the reaction coordinates, as suggested here for DHFR, then 
the Gibbs free-energy of the reaction could be expended to switch to a conformer with lower 
affinity for the product (e.g. NADP+ in DHFR) facilitating its release. The initial reactive 
configuration would then be restored either spontaneously or by expending the free-energy 
available from the binding of the substrate. The latter is observed in DHFR where the binding 
of NADPH promotes the release of tetrahydrofolate78. Hence, in DHFR the chemical step 
provides a power stroke to switch from the substrate-bound to the product-bound configuration. 
Subsequentially, the binding of the substrate provides a recovery stroke to retrieve the initial 
configuration. These concerted structural rearrangements would be especially valuable in 
complex catalysed reactions with multiple ligands where product release is the rate-limiting 
step. 
3.4  Additional results and discussion 
 
Binding constants inside the nanopore 
The association rate constants (kon) of the ligands to E1, E2 and E3 were determined from the 
slope of the inverse of the inter-event times versus the concentration of the ligand tested, while 
the ligand dissociation rate constants (koff) were retrieved from the inverse of the ligand-induced 
dwell times (Supplementary Fig. 3, Supplementary Table 3). At -80 mV, the dissociation 
rate constants for folate and NADPH binding to E1 corresponded reasonably well to the 
dissociation constants measured in bulk (Supplementary Table 3). However, the association 
binding constants were lower. This is because NADPH and folate have a -3 and -2 net negative 
charge, respectively, and their diffusion inside the nanopore is influenced by the electric field. 
As previously described for the capture of DNA by nanopores79, the capture frequency might 






       (eq 1) 
were ∆G |V| (∆GV) is the energy barrier for the diffusion of a negatively charged molecule 
across the nanopore under a negatively applied potential V, T is the temperature and R is the 
gas constant. Fitting the voltage dependency of the association rates (Supplementary Fig. 3) 
to equation 1 allows retrieving the association rate constants at vanishing small potentials 
(kon
0mV) and the voltage energy barrier for the diffusion of the analytes across the nanopore 
(∆GV). kon
0mV values for E1 blockades corresponded well to the association and dissociation 
rate constants measured in bulk for NADPH and folate (Supplementary Table 3). The voltage 
energy barrier for NADPH diffusion measured with E1 and E2 (∆GV = 322.7 ± 15.3 and 348.3 
± 41.8 J mol-1 V-1) were comparable. Also similar were the voltage energy barrier for folate 
binding to E1 and E3 (∆GV = 136.0 ± 11.6 and 115.3 ± 15.3 J mol
-1 V-1), further confirming 





between the ∆GV for NADPH and folate is most likely related to the different net charge (-3 
and -2, respectively) and mass (745 g/mol and 441 g/mol) between the two ligands.  
 
Methotrexate conformers 
When we tested the binding of methotrexate (trans) to DHFRtag (cis) in the presence of NADP
+ 
(cis), we could distinguish four different behaviours, most likely reflecting the binding of the 
ligands to the four DHFR conformers. At low methotrexate concentration (0.7 µM) 47.1 ± 2.0% 
of blockades showed methotrexate binding, while the remaining blockades did not show 
additional binding events. When a higher concentration of methotrexate was tested (20.0 µM), 
all DHFRtag molecules were observed to bind methotrexate, although only half of the low-
binding-affinity methotrexate blockades showed additional NADP+ events. By contrast, all 
DHFRtag:MTX blockades showed NADPH binding, although no dissociation of NADPH from 
the complex was observed. The four methotrexate conformers could be assigned to E1, E2, E3 
and E4 by comparing with experiments performed with folate (Supplementary Fig. 4). Folate 
binds to two conformers of DHFR, E1 and E3, most likely corresponding to the high-affinity 
methotrexate-binding conformers. E1 was assigned to the conformer that could bind to NADP+ 
because it occurred at comparable frequency as E1 when folate was tested (30.5 ± 2.7% and 
24.1 ± 5.6%, respectively, Supplementary Fig. 4). Consequentially, the high-affinity 
methotrexate-binding conformers that could not bind to NADP+ was assigned to E3. The 
percentage of E3 occurrence (16.6 ± 1.0%), was comparable to frequency of E3 measured with 
folate (11.1 ± 2.3%, Supplementary Fig. 4). The low-affinity methotrexate-binding 
conformers are then assigned to E2 and E4. The conformer that could bind to NADP+ was then 
assigned to E2. This is because conformer E2 of DHFR can still bind to NADPH.  
 
Properties of mutated DHFR’s 
In this work we used a construct that contains no cysteine residues (C85A, C152S), a C-terminal 
tag (27 additional amino acids) and two mutations to the body (T68E, R71E). The cysteine 
residues were removed for practical reasons, as their oxidation would bring two additional 
negative charges that would have a strong influence on the trapping time of DHFRtag and bring 
heterogeneity in our single-molecule results. We performed additional tests to establish the 
effect of the mutations and / or additions on the properties of the enzyme. The two mutations in 
the body of DHFRtag were introduced to allow the trapping of the protein inside the nanopore
59. 
Although, the presence of two conformers in wild-type DHFR has been established by ensemble 
experiments22–25,30,62–67, it is important to establish whether the mutations introduced to trap 
DHFRtag inside the nanopore have changed the role of conformers in the reaction cycle. 
 
Many previous studies have replaced cysteine residues with the residues we use here, and no 
kinetic anomalies have not been reported80–83. Nonetheless, we have reintroduced the cysteine 
residues and found that the four conformers were also present (Supplementary Fig. 7), 
suggesting that the cysteine residues did not change the conformer distribution. The amino acid 
substitutions in the body of DHFRtag were carefully chosen to minimize their impact on the 
properties of the enzyme. The two additional negative charges (T68E and R71E) were 
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introduced to the surface of DHFRtag away from the active site. In addition, the two native 
residues were both hydrophilic and were exchanged for two hydrophilic residues (two glutamic 
acid residues). Hence, these modifications are not expected to have an effect on the 
structure/function of the enzyme. Importantly, the residues were chosen from non-conserved 
amino acids59. In fact, several homologous DHFR have a negatively charged residue at the 
positions we added the glutamic acid residues. For these reasons we believe it is extremely 
unlikely these mutations can affect the conformer distribution of DHFR. Nonetheless, to further 
prove this point, we tested the individual mutations (T68E and R71E, named O1A and O1B) 
using electrical experiments. Despite the recordings were noisier, we found that both DHFRtag 
versions showed the same four conformers as the O2 variant we used in this work 
(Supplementary Fig. 8). Unfortunately, the WT sequence could not be trapped inside the 
nanopore for meaningful electrical experiments.  
 
KM and kcat values were also measured for the different mutants. The KM for both dihydrofolate 
and NADPH were identical to the KMs measured for the wild type DHFR (Supplementary 
Table 1). We found, however, a ~50% reduced kcat (Supplementary Table 1) in the variants 
baring the multi-lysine tag. Comparison between WT-DHFR-his (Wild-type DHFR containing 
a his-tag at the N-terminus) and WT-Strep (Wild-type-DHFR plus a Strep-Tactin tag at the C-
terminus), with WT-DHFR7+ (WT-DHFR plus the trapping tag and a Strep-Tactin tag at the C-
terminus) revealed this effect is indeed due to the positively charged tag (Supplementary 
Table 1). A likely explanation is that in ensemble experiments the positively charged tag (+7 
net charge considering the C-terminus) interacts with the negative charges of DHFR (-10 net 
charge). It should be noted, however, that inside the nanopore the electrostatic interactions 
between the protein and the tag are most likely minimal. This is because only one protein is 
inside the nanopore, hence cross interactions are prevented. Further, recent work revealed that 
inside ClyA, the tag is stretched away from the body of DHFR and it is tightly interacting with 
the trans exit of the nanopore59, indicating that intramolecular interactions between the tag and 
the DHFR body are also prevented. This interpretation is supported by the observation that the 
KD, on and off rates measured for DHFRtag inside the nanopore corresponded well with the KD, 
on and off rates measured for WT-DHFR in ensemble experiments (Supplementary Table 3).  
 
Most importantly, as described in the manuscript, ensemble experiments found that incubation 
with NADPH, changing the pH of the solution, and one mutation in DHFR (D27N) alter the 
conformer distribution. D27 is in the active site of DHFR near the M20 loop. The latter adopts 
different positions during DHFR catalysis, and it is a probable candidate to define the different 
conformers of DHFR. Electrical recordings found that D27N-DHFRtag (Fig. 4D) showed the 
same change in conformer distribution as observed in ensemble experiments using DHFR30. 
Similarly, we found that incubation with NADPH (Fig. 4A-C) or changing the pH of the 
solution (Fig. 4D) altered the conformers distribution of DHFRtag reflecting the observations in 
ensemble experiments for DHFR30,62. These results are important because they suggest that the 






3.5  Materials and methods 
 
Unless otherwise specified all chemicals were bought from Sigma-Aldrich. DNA was 
purchased from Integrated DNA Technologies (IDT), enzymes from Fermentas and lipids from 
Avanti Polar Lipids. All errors in this work are given as standard deviations. 
 
Protein and DNA sequences used in this work 












































































































































Construction DHFR mutants D27N and G121V 
The D27N-DHFRtag and G121V-DHFRtag were constructed using the QuickChange protocol
84 
for site-directed mutagenesis using a circular plasmid template DNA (pT7-SC1)80 containing 
the gene for DHFRtag
59 using Phire® Hot Start Polymerase (Finnzymes). To construct the 
DHFRtag-D27N and DHFRtag-G121V, the DHFRtag circular DNA template was amplified using 
7+O2 D27N frwd (forward) and 7+O2 D27N rev (reverse), and the 7+O2 G121V frwd 
(forward) and 7+O2 G121V rev (reverse) primers, respectively (Supplementary Table 5). The 
following PCR reaction was used: 6 µM forward and 6 µM reverse primer were mixed in 50 
µL final volume, which contained ~200 ng of template plasmid and Phire Hot Start II DNA 
polymerase (Finnzymes) and 0.4 mM dNTPs. The solution was pre-incubation at 98 °C for 30s, 
then 30 cycles of: denaturation at 98 °C for 5 s, extension at 72 °C for 1.5 min. The PCR product 
was incubated with DpnI (1 FDU) for 1 h at 37 °C to digest the plasmid template. Then DpnI 
was deactivated at 55 °C. The DNA mixture was then incorporated into E. cloni® 10 G cells 
(Lucigen) by electroporation. Transformants containing the plasmid were grown overnight at 
37 °C on LB agar plates supplemented with 100 μg/mL ampicillin and 1% glucose. Single 
colonies were picked and inoculated into 10 mL LB medium supplemented with 100 mg/l of 
ampicillin for plasmid DNA preparation. The presence of the mutation was confirmed by 
sequencing the plasmid. 
 
Construction of DHFR7+O1A, and DHFR7+O1B 
The DHFR7+O1A and DHFR7+O1B were constructed using the MEGAWHOP procedure
85 
using a circular plasmid template DNA (pT7-SC1 containing the DHFRtag gene). The DHFRtag 
circular DNA template was amplified using O1A_E68T (forward) and T7 terminator primer 
(reverse), or the O1B_E71R (forward) and T7 terminator primer (reverse), respectively 
(Supplementary Table 5) using in the following PCR reaction: REDTaq ReadyMix, 100 ng 
template DNA, 2 µM of each primer in 200 µL final volume. The reaction mixture was pre-
incubated at 95 °C for 3 minutes, then 30 cycles were applied consisting of: denaturation at 95 
°C for 15 seconds, annealing at 55 °C for 15 seconds, and extension at 72°C for 3 minutes. The 
PCR products were pooled together, gel purified (QIAquick Gel Extraction Kit, Qiagen) and 
cloned into pT7-SC1 by the following procedure: ~500 ng of the purified PCR product was 
mixed with ~300 ng of pT7-SC1 plasmid containing DHFRtag gene and the amplification was 
carried out with Phire Hot Start II DNA polymerase (Finnzymes). The PCR conditions: 500 ng 





After pre-incubation at 98 °C for 30 seconds 30 PCR cycles were applied: denaturation 98 °C 
for 5 seconds, extension 72 °C for 1.5 minute. The circular template was then eliminated by 
incubation with Dpn I (1 FDU) for 1 hour at 37 °C. 0.6 µL of the resulting mixture was 
transformed into 50 µL of E. cloni® 10G cells (Lucigen) by electroporation. The transformed 
bacteria were grown overnight at 37 °C on ampicillin (100 µg mL-1). 
 
Construction of cysteine-free DHFR7+ sequence  
The cysteine-free DHFR7+ were constructed using the MEGAWHOP procedure
85 on a circular 
plasmid template DNA (pT7-SC1 containing the DHFRtag gene). To construct the cysteine-free 
DHFR7+, the DHFRtag circular DNA template was amplified using Fwd_T68E_R71E (forward) 
and T7 terminator primer (reverse)(Supplementary Table 5) in the same protocol and method 
as described above.  
 
Construction of DHFR7+ sequence  
The DHFR7+ and DHFR7+O2 with cysteine residues were constructed using the MEGAWHOP 
procedure85 on a circular plasmid template DNA (pT7-SC1 containing the DHFR7+ or the 
DHFRtag gene respectively). To construct the DHFR7+ with cysteine residues, the circular DNA 
template was amplified using A85C (forward) and S152C primers (reverse)(Supplementary 
Table 5), in same protocol and method as described above. 
 
Construction of WT-DHFR-strep sequence  
The WT-DHFR-strep were constructed using the MEGAWHOP procedure
85 on a circular 
plasmid template DNA (pT7-SC1 containing the WT-DHFR-his gene). The WT-DHFR-his 
circular DNA template was amplified using His_to_strep_fwd (forward) and His_to_strep_rev 
(reverse) primer (Supplementary Table 5) using in the following PCR reaction: REDTaq 
ReadyMix, 100 ng template DNA, 2 µM of each primer in 200 µL final volume. The reaction 
mixture was pre-incubated at 95 °C for 3 minutes, then 30 cycles were applied consisting of: 
denaturation at 95 °C for 15 seconds, annealing at 55 °C for 15 seconds, and extension at 72°C 
for 3 minutes. The PCR products were pooled together, gel purified (QIAquick Gel Extraction 
Kit, Qiagen) and digested with NcoI and Hind III, and ligated together using T4 ligase 
(Fermentas). 0.5 µL of the ligation mixture was transformed into 50 µL of E. cloni® 10G cells 
(Lucigen) by electroporation. The transformed bacteria were grown overnight at 37 °C on 
ampicillin (100 µg mL-1) LB agar plates. The identity of the clones were confirmed by 
sequencing. 
 
Overexpression of DHFRtag proteins 
The pT7-SC1 plasmid containing the DHFRtag genes were transformed into E. cloni® 
EXPRESS BL21(DE3) cells (Lucigen), and transformants were selected on LB agar plates 
supplemented with 100 µg/mL ampicillin after overnight growth at 37 ˚C. The resulting 
colonies were grown at 37 ˚C in 2xYT medium supplemented with 100 µg/mL ampicillin until 
the optical density at 600 nm (OD600) reached ~0.8 (200 rpm shaking). The DHFRtag expression 
was subsequently induced by addition of 0.5 mM IPTG (isopropyl β-D-1-
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thiogalactopyranoside), and the temperature was switched to 25 ºC for overnight growth (200 
rpm shaking). The next day the bacteria were harvested by centrifugation at 6000xg at 4 ºC for 
25 min and the resulting pellets were frozen at -80 ºC until further use. 
 
Purification of DHFRtag proteins  
Bacterial pellets originating from 50 mL culture were resuspended in 30 mL lysis buffer (150 
mM NaCl, 15 mM Tris-HCl pH 7.5, 1 mM MgCl2, 0.2 units/mL DNaseI, 10 µg/mL lysozyme) 
and incubated at 37 ºC for 20 min. After further disruption of the bacteria by probe sonication 
the crude lysate was clarified by centrifugation at 6000xg at 4 ˚C for 30 min. For overexpressed 
proteins containing a Strep-tag, the supernatant was allowed to bind to ~150 µL (bead volume) 
of Strep-Tactin® Sepharose® (IBA) pre-equilibrated with the wash buffer (150 mM NaCl, 15 
mM Tris-HCl pH 7.5) - "end over end" mixing. The resin was then loaded onto a column (Micro 
Bio Spin, Bio-Rad) and washed with ~20 column volumes of the wash buffer. Elution of 
DHFRtag from the column was achieved by addition of ~100 µL of elution buffer (150 mM 
NaCl, 15 mM Tris-HCl pH 7.5, ~15 mM D-Desthiobiotin (IBA)). Proteins were aliquoted and 
frozen at -20 ºC until further use. New aliquots of DHFRtag were thawed prior to every 
experiment. When proteins contained cysteine residues, 1 mM DTT (Dithiothreitol) was added 
until the final step of purification, which included the washing and elution of the Strep-Tactin® 
Sepharose resin.  
The purification of DHFR with his-tag was performed as described in above, however, the 
supernatant was mixed with 200 µL of Ni-NTA resin (Qiagen) equilibrated in wash buffer. 
After 1 hr, the resin was loaded into a column (Micro Bio Spin, Bio-Rad) and washed with ~5 
mL of the wash buffer. DHFR was eluted with approximately ~0.5 mL of wash buffer 
containing 500 mM Ethylenediaminetetraacetic acid (EDTA). 
 
His-tagged Type I ClyA-AS protein overexpression and purification  
E. cloni® EXPRESS BL21 (DE3) cells were transformed with the pT7-SC1 plasmid containing 
the ClyA-AS gene. ClyA-AS contains eight mutations relative to the S. Typhi ClyA-WT: C87A, 
L99Q, E103G, F166Y, I203V, C285S, K294R and H307Y (the H307Y mutation is in the C-
terminal hexahistidine-tag added for purification).51 Transformants were selected after 
overnight growth at 37 ºC on LB agar plates supplemented with 100 µg/mL ampicillin. The 
resulting colonies were grown at 37 ˚C (200 rpm shaking) in 2xYT medium supplemented with 
100 µg/mL ampicillin until the O.D. at 600 nm was ~0.8. ClyA-AS expression was then induced 
by addition of 0.5 mM IPTG, and the temperature was switched to 25 °C for overnight growth 
(200 rpm shaking). The next day the bacteria were harvested by centrifugation at 6000xg for 
25 min at 4 °C and the pellets were stored at -80 ºC. 
Pellets containing monomeric ClyA-AS arising from 50 mL culture were thawed and 
resuspended in 20 mL of wash buffer (10 mM imidazole, 150 mM NaCl, 15 mM Tris-HCl pH 
7.5), supplemented with 1 mM MgCl2 and 0.2 units/mL of DNaseI. After lysis of the bacteria 
by probe sonication, the crude lysates were clarified by centrifugation at 6000xg for 20 min at 
4 °C and the supernatant was mixed with 200 µL of Ni-NTA resin (Qiagen) equilibrated in 





washed with ~5 mL of the wash buffer. ClyA-AS was eluted with approximately ~0.5 mL of 
wash buffer containing 300 mM imidazole. ClyA-AS monomers were stored at 4˚C until further 
use.  
ClyA-AS monomers were oligomerized by addition of 0.5% β-dodecylmaltoside (DDM, 
GLYCON Biochemicals, GmbH) and incubation at 37 ºC for 30 min. ClyA-AS oligomers were 
separated from monomers by blue native polyacrylamide gel electrophoresis (BN-PAGE, Bio-
rad) using 4-20% polyacrylamide gels. The bands corresponding to Type I ClyA-AS were 
excised from the gel and placed in 150 mM NaCl, 15 mM Tris-HCl pH 7.5, supplemented with 
0.2% DDM and 10 mM EDTA to allow diffusion of the proteins out of the gel. The 
concentration of the proteins were measured using the Bradford assay. 
 
lectrical recordings in planar lipid bilayers 
By convention the applied potential refers to the potential of the trans electrode in the planar 
lipid bilayer set up. ClyA-AS nanopores were inserted into lipid bilayers from the cis 
compartment, which is connected to the ground electrode. The cis and trans compartments are 
separated by a 25 mm thick polytetrafluoroethylene film (Goodfellow Cambridge Limited) 
containing an aperture of ~100 μm in diameter. The aperture was pre-treated with a solution of 
hexadecane [10% (v/v) in pentane] to leave a hydrophobic coating to support bilayer formation. 
1,2-diphytanoyl-sn-glycero-3-phosphocholine (DPhPC) in pentane (10 mg/mL) was then added 
to the buffer (500 µL, 250 mM KCl, 15 mM Tris-HCl, pH 7.8) present in both compartments. 
After evaporation of the pentane, a lipid monolayer at the air-water interface can self-assemble 
spontaneously by lowering and raising the buffer across the aperture. Typically, the addition of 
0.01-0.1 ng of pre-oligomerised ClyA-AS to the cis compartment (0.5 mL) was sufficient to 
obtain a single channel. Since ClyA-AS nanopores displayed a higher open-pore current at 
positive than at negative applied potentials, the orientation of the pore could be easily assessed. 
Electrical recordings were carried out in in 250 mM KCl, 15 mM Tris-HCl pH 7.8 at room 
temperature (23 °C) at -80 mV.  
 
Data recording and analysis 
Electrical signals from planar lipid bilayer recordings were amplified using an Axopatch 200B 
patch clamp amplifier (Axon Instruments) and digitized with a Digidata 1440 A/D converter 
(Axon Instruments). Data were recorded using the Clampex 10.5 software (Molecular Devices) 
and the subsequent analysis was carried out with the Clampfit software (Molecular Devices). 
Electrical recordings were carried out in 250 mM KCl, 15 mM Tris-HCl pH 7.8 at room 
temperature (23 °C) at -80 mV, by applying a 2 kHz low-pass Bessel filter and a 10 kHz 
sampling rate.  
Residual current values (Ires%) of the different DHFRtag blockades were calculated by Ires% = 
Ib/Io * 100, in which Ib represents the ionic current flowing through the pore during a blockade 
and and Io the open-pore current. Ib and Io values were calculated from Gaussian fits to all point 
current histograms (0.1 pA bin size) from at least 3 individual single channels each displaying 
at least 50 current blockades. For analysis of ligand binding events to DHFRtag traces were 
filtered digitally with a Gaussian low-pass filter with a 100 Hz cut-off. Current transitions from 
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L1 to L1ligand were analysed with the ‘single channel search’ option in Clampfit. The detection 
threshold to collect the ligand-induced events was set to 2 pA and events shorter than 0.1 ms 
were ignored. The process of event collection was monitored manually. The resulting event 
dwell times (toff) and the times between events (ton) were binned together as cumulative 
distributions and fitted to a single exponential to retrieve the ligand-induced lifetimes (τoff) and 
the ligand-induced inter-event times (τon). The average amplitude of the events was derived 
from Gaussian fits to the conventional distributions of the events´ amplitudes. Values for koff 
were determined as 1/τoff, and the values for kon were determined by kon = 1/(τon*[C]) with [C] 
the concentration of ligand added to the cis and/or trans solution. Final values for τon, τoff, kon, 
koff and event amplitudes are the averages derived from three single channel experiments, each 
analysing at least 100 binding events on more than five different DHFRtag blockades. Graphs 
were made with Origin (OriginLab Corporation). Errors are shown as standard deviations.  
 
Bulk kinetics 
The KM and kcat were measured on a Jasco V660 spectrophotometer at 25°C. All reactions were 
performed in a 1 mL reaction volume in the same buffer used for the single-molecule studies 
(250 mM KCl, 15 mM Tris, pH 7.8). Stock concentrations of DHFR were pre-incubated with 
0.35 µM of NADPH for at least 5 minutes. The reaction mixture was prepared by adding 
dihydrofolate (varying concentrations, from 1-150 µM), DHFR (75 nM) and NADPH (varying 
concentrations, from 6.25 - 250 µM). The reaction was started by the addition of dihydrofolate. 
The decrease in absorbance was monitored at 340 nm (Δε = 6220 M -1 cm-1). Errors are given 










Supplementary Table 1: Bulk kinetics data. The substrate that was varied during the kinetic analysis 
is in brackets. The buffer was 250 mM KCl, 15 mM Tris, pH 7.8 at 25 °C. Errors are given in standard 
errors as given from the fitting to the Michaelis-Menten equation (OriginLab). 
 











WT-DHFR-his 9.2 ± 2.8 1.6 ± 0.2 14.2 ± 0.4 14.5 ± 1.2 
WT-DHFR-strep 11.2 ± 2.0  2.5 ± 0.2 17.5 ± 0.4  17.0 ± 1.2 
DHFR7+ 9.4 ± 1.4 2.2 ± 0.3 7.8 ± 0.3 8.8 ± 0.5 
DHFR7+ T68E 9.3 ± 2.8 1.9 ± 0.2 6.6 ± 0.2 6.8 ± 0.6 
DHFR7+ R71E 11.3 ± 2.5 2.1 ± 0.3 5.8 ± 0.2 6.1 ± 0.4 
DHFRtag 11.8 ± 2.1 2.0 ± 0.3 5.9 ± 0.3 8.8 ± 0.6 
 
 
Supplementary Table 2: Binding of ligands to DHFRtag at -80 mV. DHFRtag, NADPH and folate 
were added in cis, methotrexate in trans. Error are given as standard deviation between independent 
















E1 NH 75.7±0.3 77.0±0.3 1.36±0.04 3.7±0.1 2.3±0.1x105 8.9±0.8 
E2 NH 75.4±0.3 76.7±0.3 1.25±0.03 3.4±0.1 1.2±0.1x105 59.7±3.4 
E1 MTX 75.8±0.2 76.5±0.2 0.67±0.03 1.8±0.1 2.4±0.1x106  0.10±0.01  
E2 MTX 75.7±0.1 76.6±0.2 0.87±0.04 2.3±0.1 8.1±0.9x103 ND 
E3 MTX 75.9±0.2 76.6±0.1 0.69±0.05 1.9±0.2 1.3±0.1x106  0.15±0.01 
E4 MTX 75.7±0.2 76.8±0.3 1.09±0.03 2.8±0.1 8.9±0.5x103 ND 
E1 Folate 75.7±0.4 76.4±0.4 0.79±0.02 2.1±0.1 3.1±0.3x106 73.5±4.8 
E3 Folate 76.0±0.1 76.6±0.3 0.61±0.05 1.7±0.1 8.3±0.3x105 268.3±26.7 
E1:NH Folate 75.7±0.3 77.6±0.3* 1.89±0.05* 5.0±0.1* N.D. N.D. 
E1:NH MTX 76.1±0.1 77.9±0.1* 1.84±0.10* 4.7±0.2* N.D. N.D. 
E2:NH MTX 75.8±0.1 77.8±0.2* 1.99±0.10* 5.0±0.4* N.D. N.D. 
D27N-E1 NH 75.9±0.1 77.4±0.2 1.45±0.03 3.6±0.2 5.9±0.5x105 8.0±0.7 
D27N-E2 NH 75.6±0.1 76.9±0.1 1.38±0.02 3.5±0.1 2.9±0.5x105 44.8±2.9 
* These values represents the value of the ternary complex 
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Supplementary Table 3: Table with kinetic constants for the different conformers. kon (0 mV) 
represents the on rate extrapolated at zero applied potential from Supplementary Figure 3. In nanopore 
experiments, the kd is calculated as koff / kon (0 mV).  
 
Enzyme Ligand kon 





E1 NADPH  5.0 ± 1.1 (0 mV) 
0.23 ± 0.1 (-80 mV)  
8.0 ± 1.0* 
 
1.6 ± 0.4 
E2 NADPH  4.1 ± 1.7 (0 mV) 
0.12 ± 0.01 (-80 mV)  
62.7 ± 8.0* 
 
15.3 ± 6.6 
E1 Folate  17 ± 2 (0 mV) 
5.0 ± 0.8 (-80 mV) 
81.9 ± 7.1* 4.8 ± 0.7 
E3 Folate  2.0 ± 0.1 (0 mV) 
0.87 ± 0.09 (-80 mV) 
308.7 ± 51.8* 154.4 ± 27.0 
Bulk 



































































Supplementary Table 4: Table with individual values used in the histograms. 




E1 (%) E2 (%) E3 (%) E4 (%) 
Figure 3b, Figure 4c and 
supplementary figure 7 


























Figure 4a, Figure 4d and 




























































Figure 4c and supplementary 
figure 4b 




















































Supplementary figure 2a 




































Supplementary figure 2b and 














Supplementary figure 4b  













Supplementary figure 7 
DHFRtag (+ cysteines) + 
















*E2 + E4 taken together 
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Supplementary Figure 1: Interconversion between conformers. (A) Zoom-ins on DHFRtag current 
blockades showing interconversion between NADPH-binding conformers. The different conformers are 
labelled with a pink box (E1), a blue box (E2) or a green box (E4) above the current trace. (B) Zoom-
ins on DHFRtag current blockades showing interconversion between folate-binding conformers. E3 is 
shown by a purple box above the trace. The current trace was collected in 250 mM KCl, 15 mM Tris-
HCl pH 7.8 at 23 ºC. Data were sampled at 10 kHz and a Bessel-low pass filter with a 2 kHz cut-off was 
applied. The trace was then filtered digitally with a Gaussian low-pass filter with a 100 Hz cut-off.  
 
 




Supplementary Figure 2: Distributions of the different conformers using ClyA-AS and ClyA-AS 
Q56W and probing folate from cis or trans. (A) Histogram showing the mean occurrences of the 
different conformers (E1, E2, E4) when NADPH (26.6 µM) is added to the cis side and is captured 
inside the ClyA-AS pore (black bars) or ClyA-AS Q56W pore (grey bars). ClyA-AS Q56W has a ring 
of tryptophan residues in the lumen of the pore, which interacts with proteins lodged inside the 
nanopore89. (B) Histograms showing the mean occurrences of the different conformers (E1, E3, E4) 
when folate (33.6 µM) is added to the cis side (black bars) or the trans side (grey bars). Error bars 




Supplementary Figure 3: Concentration and voltage dependency on the binding of ligands to 
nanopore-trapped DHFRtag molecules. Closing (A) and opening (B) transition rates as a dependency 





dissociation (D) rate constants of NADPH and folate. The binding of NADPH to the E1 conformer is 
shown as black squares and to the E2 conformer as a red circle. The binding of folate to the E1 
conformer as purple triangle and to the E3 conformer as a blue triangle. The current traces were 
collected in 250 mM KCl, 15 mM Tris-HCl pH 7.8 at 23 ºC. Error bars represent the standard 
deviation between independent experiments (N = 3 independent nanopore experiments). 
 
Supplementary Figure 4: Binding of methotrexate and NADP+ to nanopore-trapped DHFRtag 
molecules. (A) Details of a DHFRtag current blockade in the presence of NADP+ (32.2 µm, cis) and 
methotrexate (20 µM, trans). Four different kinds of blockades were observed: two with high affinity 
for methotrexate (top) and two with a low affinity for methotrexate (bottom). Both groups included 
blockades that showed NADP+ binding (left), and no NADP+ binding (right). The applied potential was 
-80 mV and the solutions contained 250 mM KCl, 15 mM Tris-HCl pH 7.8 (23 °C). The recordings 
were sampled using 2 kHz filtering and 10 kHz sampling rate and filtered digitally with a Gaussian low-
pass filter with 100 Hz cut-off. (B) Histogram showing the mean occurrences of the different conformers 
when: 0.7 µM of methotrexate is added to the trans side and 32.2 µM NADP+ to the cis side (dark grey 
bars); 1.5 µM NADP+ is added the cis side and 33.6 µM folate is added the trans side (grey bars), and 
when 33.6 µM folate is added the trans side (light grey bars). Error bars represent the standard deviation 









Supplementary Figure 5: NADPH does not bind to G121V-DHFRtag. Current trace showing the 
capture of a single G121V-DHFRtag (50 nM, cis) molecule inside ClyA-AS at -80 mV applied potential 
before (left) and after (right) the addition of 80 µM NADPH to the cis compartment. No binding events 
are observed to the apo-G121V-DHFRtag. The current trace was collected in 250 mM KCl, 15 mM Tris-
HCl pH 7.8 at room temperature (23 °C), by applying a Bessel-low pass filter with a 2 kHz cut-off and 





Supplementary Figure 6: NADPH induced current levels to DHFRtag. Extended current trace 
showing a DHFRtag molecule (50 nM, cis) inside a ClyA nanopore binding to NADPH (27 μM, cis). 
The current levels corresponding to the apo-DHFRtag and NADPH-bound are indicated by a green and 





temperature was 23 oC. Traces were collected using 2 kHz filtering and 10 kHz sampling rate, and 




Supplementary Figure 7: The different conformers sampled with DHFRtag baring the two native-
cysteines. Histograms showing the mean occurrences of the different conformers for DHFRtag (T68E, 
R71E, C85A, C152A, plain bars) and one with the cysteine residues. DHFRtag+CC (T68E, R71E, striped 









Supplementary Figure 8: Sampling the four conformers in DHFR7+O1A and DHFR7+O1B. Zoom-
ins showing four typical cysteine-free DHFR7+ current blockade with just one additional negativecharge. 
(A) Typical current blockades induced by DHFR7+O1A (T68E) (~50 nM, cis) in the presence of NADPH 
(34.7 µM, cis) and folate (26.5 µM trans) showing the E1 conformer (red), E2 (blue), E3 (purple) and 
E4 (green). On the right are all-point histograms of the shown current trace at -70 mV. (B) Typical 
current blockades induced by DHFR7+O1B (R71E) (~50 nM, cis) in the presence of NADPH (34.7 µM, 
cis) and folate (14.5 µM trans) showing the E1 conformer (red), E2 (blue), E3 (purple) and E4 (green), 
with on the right showing all-point histograms of the shown current trace at -80 mV. The buffer was 
250 mM KCl, 15 mM Tris-HCl pH 7.8 at 23 ºC Data were sampled at 10 kHz and a Bessel-low pass 
filter with a 2 kHz cut-off was applied. The trace was then filtered digitally with a Gaussian low-pass 
filter with a 100 Hz cut-off.  
 
 
3.7  References 
 
1. Blake, C. C. et al. Crystallographic studies of the activity of hen egg-white lysozyme. Proc. R. 
Soc. London. Ser. B, Biol. Sci. 167, 378–88 (1967). 
2. Ma, B., Kumar, S., Tsai, C. J., Hu, Z. & Nussinov, R. Transition-state ensemble in enzyme 
catalysis: possibility, reality, or necessity? J. Theor. Biol. 203, 383–97 (2000). 
3. Hammes-Schiffer, S. & Klinman, J. Emerging concepts about the role of protein motion in 
enzyme catalysis. Acc. Chem. Res. 48, 899 (2015). 





One Primary Sequence. Biochemistry 56, 2971–2984 (2017). 
5. Murzin, A. G. Biochemistry: Metamorphic Proteins. Science (80-. ). 320, 1725–1726 (2008). 
6. Roca, M., Liu, H., Messer, B. & Warshel, A. On the Relationship between Thermal Stability 
and Catalytic Power of Enzymes †. Biochemistry 46, 15076–15088 (2007). 
7. Závodszky, P. et al. Adjustment of conformational flexibility is a key event in the thermal 
adaptation of proteins. Proc. Natl. Acad. Sci. U. S. A. 95, 7406–7411 (1998). 
8. Maglia, G., Javed, M. H. & Allemann, R. K. Hydride transfer during catalysis by dihydrofolate 
reductase from Thermotoga maritima. Biochem. J. 374, 529–535 (2003). 
9. Wrba, A., Schweiger, A., Schultes, V., Jaenicke, R. & Zavodszky, P. Extremely thermostable 
D-glyceraldehyde-3-phosphate dehydrogenase from the eubacterium Thermotoga maritima. 
Biochemistry 29, 7584–7592 (1990). 
10. Teilum, K., Olsen, J. G. & Kragelund, B. B. Protein stability, flexibility and function. Biochim. 
Biophys. Acta - Proteins Proteomics 1814, 969–976 (2011). 
11. Jaenicke, R. Do ultrastable proteins from hyperthermophiles have high or low conformational 
rigidity? Proc. Natl. Acad. Sci. 97, 2962–2964 (2000). 
12. Sawaya, M. R. & Kraut, J. Loop and Subdomain Movements in the Mechanism of Escherichia 
coli Dihydrofolate Reductase: Crystallographic Evidence † , ‡. Biochemistry 36, 586–603 
(1997). 
13. Osborne, M. J., Schnell, J., Benkovic, S. J., Dyson, H. J. & Wright, P. E. Backbone Dynamics 
in Dihydrofolate Reductase Complexes: Role of Loop Flexibility in the Catalytic Mechanism †. 
Biochemistry 40, 9846–9859 (2001). 
14. Fierke, C. A., Johnson, K. A. & Benkovic, S. J. Construction and evaluation of the kinetic 
scheme associated with dihydrofolate reductase from Escherichia coli. Biochemistry 26, 4085–
92 (1987). 
15. Zhang, Z., Rajagopalan, P. T. R., Selzer, T., Benkovic, S. J. & Hammes, G. G. Single-molecule 
and transient kinetics investigation of the interaction of dihydrofolate reductase with NADPH 
and dihydrofolate. Proc. Natl. Acad. Sci. U. S. A. 101, 2764–9 (2004). 
16. Cameron, C. E. & Benkovic, S. J. Evidence for a functional role of the dynamics of glycine-
121 of Escherichia coli dihydrofolate reductase obtained from kinetic analysis of a site-directed 
mutant. Biochemistry 36, 15792–800 (1997). 
17. Osborne, M. J., Venkitakrishnan, R. P., Dyson, H. J. & Wright, P. E. Diagnostic chemical shift 
markers for loop conformation and substrate and cofactor binding in dihydrofolate reductase 
complexes. Protein Sci. 12, 2230–2238 (2009). 
18. Wan, Q. et al. Toward resolving the catalytic mechanism of dihydrofolate reductase using 
neutron and ultrahigh-resolution X-ray crystallography. Proc. Natl. Acad. Sci. 111, 18225–
18230 (2014). 
19. Gundersen, L. E. et al. Dihydrofolate reductase from amethopterin-resistant Lactobacillus 
casei. Biochemistry 11, 1018–1023 (1972). 
20. Huennekens, F. M. et al. Dihydrofolate reductases: structural and mechanistic aspects. Ann. N. 
Y. Acad. Sci. 186, 85–99 (1971). 
21. Perkins, J. P., Hillcoat, B. L. & Bertino, J. R. Dihydrofolate reductase from a resistant subline 
of the L1210 lymphoma. Purification and properties. J. Biol. Chem. 242, 4771–6 (1967). 
22. Dunn, S. M., Batchelor, J. G. & King, R. W. Kinetics of ligand binding to dihydrofolate 
reductase: binary complex formation with NADPH and coenzyme analogues. Biochemistry 17, 
2356–64 (1978). 
23. Dunn, S. M. & King, R. W. Kinetics of ternary complex formation between dihydrofolate 
 
Directional conformer exchange in dihydrofolate reductase revealed by single-molecule nanopore recordings 
105 
 
reductase, coenzyme, and inhibitors. Biochemistry 19, 766–73 (1980). 
24. Cayley, P. J., Dunn, S. M. J. & King, R. W. Kinetics of substrate, coenzyme, and inhibitor 
binding to Escherichia coli dihydrofolate reductase. Biochemistry 20, 874–9 (1981). 
25. Baccanari, D. P., Averett, D., Briggs, C. & Burchall, J. Escherichia coli dihydrofolate 
reductase: isolation and characterization of two isozymes. Biochemistry 16, 3566–72 (1977). 
26. Chen, J. T., Taira, K., Tu, C. P. D. & Benkovic, S. J. Probing the functional role of 
phenylalanine-31 of Escherichia coli dihydrofolate reductase by site-directed mutagenesis. 
Biochemistry 26, 4093–4100 (1987). 
27. Falzone, C. J., Wright, P. E. & Benkovic, S. J. Evidence for two interconverting protein 
isomers in the methotrexate complex of dihydrofolate reductase from Escherichia coli. 
Biochemistry 30, 2184–2191 (1991). 
28. Li, L., Falzone, C. J., Wright, P. E. & Benkovic, S. J. Functional role of a mobile loop of 
Escherichia coli dihydrofolate reductase in transition-state stabilization. Biochemistry 31, 
7826–33 (1992). 
29. Cheung, H. T., Birdsall, B. & Feeney, J. 13C NMR studies of complexes of Escherichia coli 
dihydrofolate reductase formed with methotrexate and with folic acid. FEBS Lett. 312, 147–51 
(1992). 
30. Appleman, J. R., Howell, E. E., Kraut, J. & Blakley, R. L. Role of aspartate 27 of dihydrofolate 
reductase from Escherichia coli in interconversion of active and inactive enzyme conformers 
and binding of NADPH. J. Biol. Chem. 265, 5579–84 (1990). 
31. Schnell, J. R., Dyson, H. J. & Wright, P. E. Structure, dynamics, and catalytic function of 
dihydrofolate reductase. Annu. Rev. Biophys. Biomol. Struct. 33, 119–40 (2004). 
32. Shin, S. H., Luchian, T., Cheley, S., Braha, O. & Bayley, H. Kinetics of a reversible covalent-
bond-forming reaction observed at the single-molecule level. Angew. Chemie-International Ed. 
41, 3707–9; 3523 (2002). 
33. Lee, J. et al. Semisynthetic Nanoreactor for Reversible Single-Molecule Covalent Chemistry. 
ACS Nano 10, 8843–8850 (2016). 
34. Ramsay, W. J., Bell, N. A. W., Qing, Y. & Bayley, H. Single-Molecule Observation of the 
Intermediates in a Catalytic Cycle. J. Am. Chem. Soc. 140, 17538–17546 (2018). 
35. Borsley, S. & Cockroft, S. L. In Situ Synthetic Functionalization of a Transmembrane Protein 
Nanopore. ACS Nano 12, 786–794 (2018). 
36. Lu, S., Li, W. W., Rotem, D., Mikhailova, E. & Bayley, H. A primary hydrogen-deuterium 
isotope effect observed at the single-molecule level. Nat Chem 2, 921–928 (2010). 
37. Steffensen, M. B., Rotem, D. & Bayley, H. Single-molecule analysis of chirality in a 
multicomponent reaction network. Nat Chem 6, 603–607 (2014). 
38. Haugland, M. M., Borsley, S., Cairns-Gibson, D. F., Elmi, A. & Cockroft, S. L. Synthetically 
Diversified Protein Nanopores: Resolving Click Reaction Mechanisms. ACS Nano 13, 4101–
4110 (2019). 
39. Ho, C.-W. et al. Engineering a nanopore with co-chaperonin function. Sci. Adv. 1, e1500905 
(2015). 
40. Craig, J. M. et al. Revealing dynamics of helicase translocation on single-stranded DNA using 
high-resolution nanopore tweezers. Proc. Natl. Acad. Sci. U. S. A. 114, 11932–11937 (2017). 
41. Nivala, J., Marks, D. B. & Akeson, M. Unfoldase-mediated protein translocation through an α-
hemolysin nanopore. Nat. Biotechnol. 31, 247–50 (2013). 
42. Hurt, N., Wang, H., Akeson, M. & Lieberman, K. R. Specific nucleotide binding and rebinding 






43. Cockroft, S. L., Chu, J., Amorin, M. & Ghadiri, M. R. A single-molecule nanopore device 
detects DNA polymerase activity with single-nucleotide resolution. J. Am. Chem. Soc. 130, 
818–20 (2008). 
44. Cheley, S., Xie, H. & Bayley, H. A Genetically Encoded Pore for the Stochastic Detection of a 
Protein Kinase. ChemBioChem 7, 1923–1927 (2006). 
45. Howorka, S., Nam, J., Bayley, H. & Kahne, D. Stochastic Detection of Monovalent and 
Bivalent Protein–Ligand Interactions. Angew. Chemie Int. Ed. 43, 842–846 (2004). 
46. Clarke, J. et al. Continuous base identification for single-molecule nanopore DNA sequencing. 
Nat. Nanotechnol. 4, 265 (2009). 
47. Zhao, Q., de Zoysa, R. S. S., Wang, D., Jayawardhana, D. A. & Guan, X. Real-time monitoring 
of peptide cleavage using a nanopore probe. J. Am. Chem. Soc. 131, 6324–5 (2009). 
48. Lieberman, K. R. et al. Processive Replication of Single DNA Molecules in a Nanopore 
Catalyzed by phi29 DNA Polymerase. J. Am. Chem. Soc. 132, 17961–17972 (2010). 
49. Tan, C. S., Riedl, J., Fleming, A. M., Burrows, C. J. & White, H. S. Kinetics of T3-DNA 
Ligase-Catalyzed Phosphodiester Bond Formation Measured Using the α-Hemolysin 
Nanopore. ACS Nano 10, 11127–11135 (2016). 
50. Fennouri, A. et al. Kinetics of enzymatic degradation of high molecular weight polysaccharides 
through a nanopore: experiments and data-modeling. Anal. Chem. 85, 8488–92 (2013). 
51. Soskine, M., Biesemans, A., De Maeyer, M. & Maglia, G. Tuning the Size and Properties of 
ClyA Nanopores Assisted by Directed Evolution. J. Am. Chem. Soc. 135, 13456–13463 (2013). 
52. Soskine, M., Biesemans, A. & Maglia, G. Single-Molecule Analyte Recognition with ClyA 
Nanopores Equipped with Internal Protein Adaptors. J. Am. Chem. Soc. 137, 5793–5797 
(2015). 
53. Van Meervelt, V. et al. Real-Time Conformational Changes and Controlled Orientation of 
Native Proteins Inside a Protein Nanoreactor. J. Am. Chem. Soc. 139, 18640–18646 (2017). 
54. Biesemans, A., Soskine, M. & Maglia, G. A Protein Rotaxane Controls the Translocation of 
Proteins Across a ClyA Nanopore. Nano Lett. 15, 6076–6081 (2015). 
55. Van Meervelt, V., Soskine, M. & Maglia, G. Detection of two isomeric binding configurations 
in a protein-aptamer complex with a biological nanopore. ACS Nano 8, 12826–35 (2014). 
56. Galenkamp, N. S., Soskine, M., Hermans, J., Wloka, C. & Maglia, G. Direct electrical 
quantification of glucose and asparagine from bodily fluids using nanopores. Nat. Commun. 9, 
4085 (2018). 
57. Waduge, P. et al. Nanopore-Based Measurements of Protein Size, Fluctuations, and 
Conformational Changes. ACS Nano 11, 5706–5716 (2017). 
58. Hu, R. et al. Differential Enzyme Flexibility Probed Using Solid-State Nanopores. ACS Nano 
12, 4494–4502 (2018). 
59. Willems, K. et al. Engineering and Modeling the Electrophoretic Trapping of a Single Protein 
Inside a Nanopore. ACS Nano acsnano.8b09137 (2019). doi:10.1021/acsnano.8b09137 
60. Soskine, M. et al. An engineered ClyA nanopore detects folded target proteins by selective 
external association and pore entry. Nano Lett. 12, 4895–4900 (2012). 
61. Loveridge, E. J. et al. Reduction of Folate by Dihydrofolate Reductase from Thermotoga 
maritima. Biochemistry 56, 1879–1886 (2017). 
62. Penner, M. H. & Frieden, C. Substrate-induced hysteresis in the activity of Escherichia coli 
dihydrofolate reductase. J. Biol. Chem. 260, 5366–9 (1985). 
63. Baccanari, D. P. & Joyner, S. S. Dihydrofolate reductase hysteresis and its effect on inhibitor 
 
Directional conformer exchange in dihydrofolate reductase revealed by single-molecule nanopore recordings 
107 
 
binding analyses. Biochemistry 20, 1710–1716 (1981). 
64. Newbold, P. C. & Harding, N. G. Affinity chromatography of dihydrofolate reductase. 
Biochem. J. 124, 1–12 (1971). 
65. Williams, J. W., Morrison, J. F. & Duggleby, R. G. Methotrexate, a high-affinity 
pseudosubstrate of dihydrofolate reductase. Biochemistry 18, 2567–73 (1979). 
66. Williams, J. W. & Morrison, J. F. The kinetics of reversible tight-binding inhibition. Methods 
Enzymol. 63, 437–67 (1979). 
67. Pattishall, K. H., Burchall, J. J. & Harvey, R. J. Interconvertible forms of Escherichia coli 
dihydrofolate reductase with different affinities for analogs of dihydrofolate. J. Biol. Chem. 
251, 7011–20 (1976). 
68. Bystroff, C., Oatley, S. J. & Kraut, J. Crystal structures of Escherichia coli dihydrofolate 
reductase: the NADP+ holoenzyme and the folate .cntdot. NADP+ ternary complex. substrate 
binding and a model for the transition state. Biochemistry 29, 3263–3277 (1990). 
69. Bystroff, C. & Kraut, J. Crystal structure of unliganded Escherichia coli dihydrofolate 
reductase. Ligand-induced conformational changes and cooperativity in binding. Biochemistry 
30, 2227–39 (1991). 
70. Matthews, D. et al. Dihydrofolate reductase: x-ray structure of the binary complex with 
methotrexate. Science (80-. ). 197, 452–455 (1977). 
71. Rajagopalan, P. T. R. et al. Interaction of dihydrofolate reductase with methotrexate: ensemble 
and single-molecule kinetics. Proc. Natl. Acad. Sci. U. S. A. 99, 13481–6 (2002). 
72. Biesemans, A., Soskine, M. & Maglia, G. A Protein Rotaxane Controls the Trans location of 
Proteins Across a ClyA Nanopore. Nano Lett. 15, 6076–6081 (2015). 
73. Boehr, D. D., McElheny, D., Dyson, H. J. & Wright, P. E. The Dynamic Energy Landscape of 
Dihydrofolate Reductase Catalysis. Science (80-. ). 313, 1638–1642 (2006). 
74. Oyen, D. et al. Defining the Structural Basis for Allosteric Product Release from E. coli 
Dihydrofolate Reductase Using NMR Relaxation Dispersion. J. Am. Chem. Soc. 139, 11233–
11240 (2017). 
75. Boehr, D. D., McElheny, D., Dyson, H. J. & Wright, P. E. Millisecond timescale fluctuations 
in dihydrofolate reductase are exquisitely sensitive to the bound ligands. Proc. Natl. Acad. Sci. 
107, 1373–1378 (2010). 
76. Lienhard, G. E. Enzymatic Catalysis and Transition-State Theory. Science (80-. ). 180, 149–
154 (1973). 
77. Hilvert, D. Critical Analysis of Antibody Catalysis. Annu. Rev. Biochem. 69, 751–793 (2000). 
78. Oyen, D., Fenwick, R. B., Stanfield, R. L., Dyson, H. J. & Wright, P. E. Cofactor-Mediated 
Conformational Dynamics Promote Product Release From Escherichia coli Dihydrofolate 
Reductase via an Allosteric Pathway. J. Am. Chem. Soc. 137, 9459–9468 (2015). 
79. Franceschini, L., Brouns, T., Willems, K., Carlon, E. & Maglia, G. DNA Translocation through 
Nanopores at Physiological Ionic Strengths Requires Precise Nanoscale Engineering. ACS 
Nano 10, 8394–8402 (2016). 
80. Iwakura, M., Jones, B. E., Luo, J. & Matthews, C. R. A strategy for testing the suitability of 
cysteine replacements in dihydrofolate reductase from Escherichia coli. J. Biochem. 117, 480–8 
(1995). 
81. Sota, H., Hasegawa, Y. & Iwakura, M. Detection of Conformational Changes in an 
Immobilized Protein Using Surface Plasmon Resonance. Anal. Chem. 70, 2019–2024 (1998). 
82. Radkiewicz, J. L. & Brooks, C. L. Protein Dynamics in Enzymatic Catalysis: Exploration of 





83. Ionescu, R. M., Smith, V. F., O’Neil, J. C. & Matthews, C. R. Multistate Equilibrium 
Unfolding of Escherichia coli Dihydrofolate Reductase: Thermodynamic and Spectroscopic 
Description of the Native, Intermediate, and Unfolded Ensembles †. Biochemistry 39, 9540–
9550 (2000). 
84. Papworth C, Bauer JC, Braman J, W. DA. Site-directed mutagenesis in one day with >80% 
efficiency. Strategies 9, 3–3 (1996). 
85. Miyazaki, K. MEGAWHOP cloning: a method of creating random mutagenesis libraries via 
megaprimer PCR of whole plasmids. Methods Enzymol. 498, 399–406 (2011). 
86. Posner, B. A., Li, L., Bethell, R., Tsuji, T. & Benkovic, S. J. Engineering specificity for folate 
into dihydrofolate reductase from Escherichia coli. Biochemistry 35, 1653–63 (1996). 
87. Penner, M. H. & Frieden, C. Kinetic analysis of the mechanism of Escherichia coli 
dihydrofolate reductase. J. Biol. Chem. 262, 15908–14 (1987). 
88. Reddish, M. J., Vaughn, M. B., Fu, R. & Dyer, R. B. Ligand-Dependent Conformational 
Dynamics of Dihydrofolate Reductase. Biochemistry 55, 1485–93 (2016). 
89. Wloka, C. et al. Label-Free and Real-Time Detection of Protein Ubiquitination with a 
Biological Nanopore. ACS Nano 11, 4387–4394 (2017). 
